Company News »
Zoetis to Participate in the Jefferies 2015 Animal Health Summit
Zoetis Inc. (NYSE:ZTS) will participate in the Jefferies 2015 Animal Health Summit on Thursday, March 26, in New York, N.Y. Juan Ram’on Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 9:30 a.m. EDT.
The presentation is not scheduled to be webcast. Investors and other interested parties will be able to access the presentation materials at http://investor.zoetis.com/events-presentations at the conclusion of the event.
About Zoetis
Zoetis (z^o-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2014, the company generated annual revenue of $4.8 billion. With approximately 10,000 employees worldwide at the beginning of 2015, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, expectations regarding products, future use of cash and dividend payments, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.
- Help is Now Available PECO Low-Income Customers 4 views
- Circus by Sam Edelman Debuts Spring 2015 Ad Campaign 2 views
- Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance 2 views
- Macy’s, Inc. Comparable Sales Rose 2.7% on an Owned Plus Licensed Basis in November/December Period; Comparable Sales Rose 2.1% on an Owned Basis 2 views
- Logility Named a Top 20 Retail Software Provider 2 views
- GENERALIZED FOREX FORECAST FOR 29 DECEMBER 2014 – 2 JANUARY 2015 1 view
- Guidance Software Awarded 5-Star Rating in CRN’s 2015 Partner Program Guide 1 view
- ChannelAdvisor to Sponsor Demandware’s 2015 XChange Conference, April 13-15 1 view
- Western Union Offers Apple PayTM as New Pay-In Option for Money Transfer Customers 1 view
- GE Opens New Global R&D Center in Brazil;Working with Petrobras and BG Group to Develop Advanced Technologies for Oil and Gas Processing on the Seabed 1 view
Forex Broker Spreads » |
|
Most Popular Articles » |
- Help is Now Available PECO Low-Income Customers 4 views
- Circus by Sam Edelman Debuts Spring 2015 Ad Campaign 2 views
- Berry Genomics NextSeq CN500 Instrument and Non-Invasive Prenatal Testing Reagent Kit Receives Chinese FDA Premarket Clearance 2 views
- Macy’s, Inc. Comparable Sales Rose 2.7% on an Owned Plus Licensed Basis in November/December Period; Comparable Sales Rose 2.1% on an Owned Basis 2 views
- Logility Named a Top 20 Retail Software Provider 2 views
- Is the Nasdaq Oversold? 1 view
- Crude Oil Breaks Out as Inventories Finally Ease 1 view
- New Vishay Intertechnology BiSy Single-Line, Ultra-Low-Capacitance ESD Protection Diode Saves Board Space in Portable Electronics 1 view
- Invacare Corporation Announces New Credit Agreement 1 view
- Stocks Notch Up Losses for a Third Consecutive Session 1 view